Option Care Health Q3 revenue up 14.5% to $1.02B; EPS $0.21; raises full-year guidance

Option Care Health, Inc.

2022-Q3 EPS reported $0.57 revenue$2,917,522,000

Net revenue $1,020.9M, up 14.5% YoY; gross margin 21.4% vs 22.8% in Q3 2021.
Net income $38.8M ($0.21 diluted EPS) vs $35.5M ($0.20) a year ago.
Adjusted EBITDA $85.6M (8.4% of revenue), up 9.8% from $78.0M.
FY2022 guidance: net revenue $3.90-3.95B, adj. EBITDA $336-341M, cash from ops ≥$250M.
Acquired Rochester Home Infusion for $27.4M in cash; cash balance $255.5M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Option Care Health, Inc. reported third quarter ended September 30, 2022 results: revenue $1,020.9 million, net income $38.8 million, or $0.21 per share, EPS $0.21 per share. Guidance raised.

Period: third quarter ended September 30, 2022
Revenue: $1,020.9 million
Net income: $38.8 million, or $0.21 per share
EPS: $0.21 per share
Guidance: raised
Result: reported results

Exact text from the filing

and alternate site infusion services, today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Financial Highlights • Net revenue of $1,020.9 million, up 14.5% compared to $891.9 million in the third quarter of 2021 • Gross profit of $218.0 million, or 21.4% of net revenue, up 7.4% compared to $203.0 million, or 22.8% of net

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Option Care Health, Inc. filing history →

Source: SEC EDGAR

accession 0001014739-22-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.